Prot# PDX-007: A Phase 1 Open-Label Study of (RS)-10-Propargyl-10-Deazaaminopterin (PDX) with Vitamin B12 and Folic Acid Supplementation in Patients with Previously-Treated Advanced Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date6/5/07 → 11/1/11

Funding

  • Allos Therapeutics (PDX-007)